Regenxbio Inc banner

Intrinsic Value

The intrinsic value of Regenxbio Inc (RB0) under the Base Case is 10.769 EUR per share. Compared with the current market price of 7.202 EUR, the stock appears Undervalued by 33% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

RB0 Intrinsic Value
€10.769
Undervaluation 33%
Intrinsic Value
Price €7.202
Alert me when RB0 is below its intrinsic value
Today €6.462 · 10.3% below the current price

RB0 is cheaper than usual. It was this cheap or cheaper on just 5% of days in the past 5 years.

Alternatives to RB0

Fundamental Analysis

What Regenxbio Does

Biotechnology Health Care

Regenxbio is a biotechnology company that develops gene therapy medicines. It works by designing viral vectors that can deliver working genes into a patient’s cells, mainly for rare and serious diseases. The company’s business is built around research, clinical development, and licensing its gene therapy technology to drug makers that want to use it in their own programs.

Headquarters
United States of America US
Employees
371
IPO date
Sep 17, 2015
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 5, 2026

REGENXBIO is nearing pivotal sura-vec readouts while advancing RGX-202 toward a full BLA filing, with both programs central to its preparations for potential commercialization.

Open the earnings call
EPS
−$0.62
Expected
−$1.35
Surprise
+54.1%
Stock, day of the call
−4.3%
View Earnings Call

Regenxbio insiders made their first purchases in five years

Insider trading · Last trade on Aug 27, 2026

Sold $940k 1 insider
Bought $949.4k 1 insider
Trades by date
Open insider trading

Past 12 months

Continue RB0 Research

Decided on Regenxbio? Get an email when RB0 reaches the price you’d buy at. Free with an account.

Other Regenxbio listings

What is the Intrinsic Value of one RB0 stock?

The intrinsic value for Regenxbio Inc (RB0) under the Base Case is 10.769 EUR.

Is RB0 stock undervalued or overvalued?

Compared with the current market price of 7.202 EUR, the stock appears Undervalued by 33% .

How reliable are our estimates? See how past valuations played out
Back to Top